Sangamo Biosciences (SGMO) CFO to Retire; Successor Named

February 27, 2017 4:53 PM

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), the leader in therapeutic genome editing, today announced the appointment of Kathy Yi as senior ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found